Consensus Clinuvel Pharmaceuticals Limited

Equities

Delayed Australian S.E. Other stock markets 10:26:43 2024-04-28 pm EDT			5-day change	1st Jan Change
14.86 ^AUD	+1.99%		+4.14%	-7.25%

Mar. 14	Clinuvel Pharmaceuticals Launches Share Buyback Program	MT
Mar. 14	Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16	MT

0.IFQid15NzE7-toBaWWB1khAfUAq4ssHoAt4TXD5rjXQ.RmJXGScAvgqX8_IoKVEM4VEnM3Ds9qi7TaRYNFMv-SBqAREHATmYKqvFxQ~3711407c5dd41db3d14fcc450bb54c35

Mar. 13

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

14.57 AUD

Average target price

25.6 AUD

Spread / Average Target

+75.72%

High Price Target

46.3 AUD

Spread / Highest target

+217.78%

Low Price Target

16 AUD

Spread / Lowest Target

+9.81%

Morgans Financial

Trading Rating

Investor Rating

ESG Refinitiv